FIELD: medicine; pulmonology. SUBSTANCE: method involves inhalation of 1 therapeutic dose (0.04 mg) of iprathropium bromide by patient before 10-15 min of additional respiratory resistance. EFFECT: increased endurance to additional respiratory resistance.
| Title | Year | Author | Number |
|---|---|---|---|
| PNEUMATIC DEVICE FOR METERING EXTERNAL RESPIRATION RESISTANCE | 1993 |
|
RU2071790C1 |
| METHOD OF TREATMENT OF SLEEP APNEA SYNDROME | 1996 |
|
RU2136260C1 |
| METHOD FOR CHANGING BOTH COAGULATING AND ANTICOAGULATING BODY SYSTEMS | 1998 |
|
RU2188014C2 |
| METHOD FOR INCREASING TOLERANCE TO INCREASED BREATHING RESISTANCE | 2020 |
|
RU2749806C1 |
| DEVICE FOR CARRYING OUT AEROSOL THERAPY | 1993 |
|
RU2071789C1 |
| METHOD FOR STIMULATING NONSPECIFIC RESISTANCE | 1997 |
|
RU2147445C1 |
| METHOD FOR IMMUNITY CONTROL | 2000 |
|
RU2195967C2 |
| METHOD FOR APPLYING ANTICOAGULATION THERAPY | 1997 |
|
RU2149031C1 |
| METHOD OF DIAGNOSTICS OF OBSTRUCTIVE DISORDERS OF EXTERNAL RESPIRATION BY USE OF CAPNOGRAPHY | 2006 |
|
RU2324508C2 |
| METHOD FOR MODELING ARTERIAL HYPERTENSION | 1993 |
|
RU2071717C1 |
